NYSE · Basic Materials · Specialty Chemicals · USA
Albemarle Corp is a large cap company (market value between $10 billion and $200 billion) in the Specialty Chemicals industry.
Albemarle develops and manufactures lithium compounds, bromine-based specialty chemicals, and catalysts for refining and petrochemical applications. The company serves customers in grid storage, automotive, aerospace, energy, electronics, construction, agriculture, pharmaceuticals and medical devices across multiple countries. Its operations are organized into three segments: Energy Storage, Specialties, and Ketjen.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Albemarle Corp stock.
Overvalued: intrinsic value $60.60 per share, market price $95.77, margin of safety -58.0% (as of 2026-10-20).
Its through-the-cycle earnings (17.4% median margin), capitalised at 10.0% with no growth, values the shares at $60.60; the price of $95.77 is 58% above that value.
Leak Score: 47/100 on 11 of 12 signals (On Watch).
17 more funds hold it; the full list is part of the paid plan.
All 62 Specialty Chemicals stocks
22 more in this industry show a wider margin of safety.
ALB is overvalued (as of the 2026-10-20 close). Its through-the-cycle earnings (17.4% median margin), capitalised at 10.0% with no growth, values the shares at $60.60; the price of $95.77 is 58% above that value.
$60.60 per share (as of the 2026-10-20 close), against a market price of $95.77. That is a margin of safety of -58.0%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
47 out of 100, which we rate "On Watch", on 11 of 12 value investing signals.